Showing results (11-20 of 42) with videos related to

Sort By:
Pageof 5
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|July 18, 2008
AA amyloidosis due to chronic oxalate arthritis and vasculitis in a patient with secondary oxalosis after jejunoileal bypass surgeryTom Cornelis, Bert Bammens, Evelyne Lerut, et al.
Blood Purification|January 25, 2012
Renal replacement therapy in geriatric end-stage renal disease patients: a clinical approachJeroen P Kooman, Tom Cornelis, Frank M van der Sande, et al.
Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis|June 19, 2010
Discordant PD catheter and effluent culture results. The limited clinical relevance of culturing PD cathetersTom Cornelis, Joanne M Bargman, Maggie Chu, et al.
The Journal of Vascular Access|March 10, 2015
Revision techniques for failed PD catheters: outcome in a University HospitalArnoud Gerardus Peppelenbosch, Jorinde van Laanen, Tom Cornelis, et al.
Journal of Gastroenterology and Hepatology|May 10, 2008
Cholestatic liver disease in long-term infantile nephropathic cystinosisTom Cornelis, Kathleen Claes, Pieter Gillard, et al.
Plos One|January 23, 2016
Protein-Bound Uremic Toxin Profiling as a Tool to Optimize HemodialysisSunny Eloot, Daniel Schneditz, Tom Cornelis, et al.
Seminars in Dialysis|November 30, 2011
Can intensive hemodialysis prevent loss of functionality in the elderly ESRD patient?Tom Cornelis, Peter Kotanko, Eric Goffin, et al.
Seminars in Dialysis|October 20, 2012
Intensive hemodialysis in the (nursing) home: the bright side of geriatric ESRD care?Tom Cornelis, Peter Kotanko, Eric Goffin, et al.
Clinical Toxicology (Philadelphia, Pa.)|April 3, 2012
Bortezomib-associated fatal liver failure in a haemodialysis patient with multiple myelomaTom Cornelis, Erik A M Beckers, Ann L C Driessen, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|June 11, 2013
Reasons for dose reduction of mycophenolate mofetil during the first year after renal transplantation and its impact on graft outcomeThomas Vanhove, Dirk Kuypers, Kathleen J Claes, et al.
Pageof 5